Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
ABOS
ABOS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ABOS News
Healthcare Stocks Surge in After-Hours Trading
Jan 28 2026
NASDAQ.COM
Wall Street Analysts Adjust Ratings
Jan 27 2026
Benzinga
Alumis Inc. (ALMS) Shares Surge 17.33% on Phase 3 Clinical Trial Data Announcement
Jan 06 2026
NASDAQ.COM
Healthcare Stocks Surge in After-Hours Trading: KYMR, OCUL, POAI Lead the Gains
Dec 08 2025
NASDAQ.COM
Acumen Pharmaceuticals Announces Financial Results and Business Highlights for Q3 2025
Nov 12 2025
Newsfilter
VTYX, MEDP, INBX Surge in After-Hours Trading Following Important Announcements
Oct 23 2025
NASDAQ.COM
Biotech Surge on Friday: Clinical Advancements Drive Afternoon Gains
Sep 29 2025
NASDAQ.COM
Biotech Stocks Rise After Hours Following Trial News and Strategic Developments
Sep 24 2025
NASDAQ.COM
Acumen Pharma Cuts Alzheimer's Trial Costs 40% With Blood Test
Jul 28 2025
NASDAQ.COM
Acumen, JCR Pharma Join To Develop Oligomer-targeted Enhanced Brain Delivery Therapy For Alzheimers
Jul 15 2025
NASDAQ.COM
Acumen Pharmaceuticals and JCR Pharmaceuticals Enter Strategic Collaboration, Option and License Agreement to Develop Enhanced Brain Delivery™ Therapy for Alzheimer's Disease
Jul 15 2025
Newsfilter
Acumen Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025
May 06 2025
Yahoo Finance
Acumen Pharmaceuticals Showcases pTau217 Trial Screening Progress in Phase 2 ALTITUDE-AD Trial and Preclinical Research Methods at AD/PD 2025 and AAN Annual Meeting
Apr 02 2025
Newsfilter
Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors
Mar 31 2025
Globenewswire
Tesla To $345? Here Are 10 Top Analyst Forecasts For Friday
Mar 28 2025
Benzinga
Tesla To $345? Here Are 10 Top Analyst Forecasts For Friday
Mar 28 2025
Benzinga
Show More News
